Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment
.
Show all posts
Showing posts with label
Treatment
.
Show all posts
Thursday, June 16, 2022
FDA Approves Mounjaro (tirzepatide) Injection for the Treatment of Adults with Type 2 Diabetes
›
The U.S. Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-...
Tuesday, June 14, 2022
FDA Approves Radicava ORS (edaravone) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
›
Mitsubishi Tanabe Pharma Corporation (MTPA) announced the U.S. Food and Drug Administration (FDA) approval of Radicava ORS (edaravone), ...
Saturday, June 11, 2022
FDA Approves Camzyos (mavacamten) for the Treatment of Symptomatic NYHA Class II-III Obstructive Hypertrophic Cardiomyopathy
›
In continuation of my update on mavacamten Bristol Myers Squibb (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) approval...
Friday, June 10, 2022
FDA Approves Vtama (tapinarof) Cream for the Treatment of Plaque Psoriasis in Adults
›
Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, ...
Thursday, March 10, 2022
FDA Approves Recorlev (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
›
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), announce the U.S. Food and Drug Administration (FDA) approval of Recorlev ® (levoketoconazo...
Wednesday, March 9, 2022
FDA Approves Quviviq (daridorexant) for the Treatment of Adults with Insomnia
›
Idorsia Ltd (SIX: IDIA) announced the US Food and Drug Administration (FDA) approval of Quviviq (daridorexant) 25 mg and 50 mg for the ...
Friday, April 9, 2021
FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma
›
In continuation of my update on Tivozanib AVEO Oncology (Nasdaq: AVEO) announced the U.S. Food and Drug Administration (FDA) approval ...
Friday, November 13, 2020
FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease
›
The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either can...
Saturday, January 11, 2020
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
›
In continuation of my update on Otezla (apremilast) Celgene Corporation today announced that the U.S. Food and Drug Administration...
Monday, December 23, 2019
Dova Pharmaceuticals Announces FDA Approval of Doptelet (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)
›
In continuation of my update on avatrombopag Dova Pharmaceuticals, Inc. a pharmaceutical company focused on acquiring, developi...
Wednesday, October 2, 2019
FDA Approves Jakafi (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease
›
In continuation of my update on ruxolitinib Incyte Corporation announced that the U.S. Food and Drug Administration (FDA...
Friday, June 7, 2019
FDA Approves Avaclyr (acyclovir ophthalmic ointment) for the Treatment of Herpetic Keratitis
›
The US Food and Drug Administration (FDA) has approved Fera Pharmaceuticals' New Drug Application (NDA) for Avaclyr (acyclo...
Friday, March 22, 2019
AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
›
In continuation of my update on upadacitinib AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has a...
›
Home
View web version